Global Recombinant DNA Vaccines Market Research Report 2016

August 2016 | 119 pages | ID: G1C4C7FF533EN
QYResearch

Abstracts

Notes:

Production, means the output of Recombinant DNA Vaccines

Revenue, means the sales value of Recombinant DNA Vaccines

This report studies Recombinant DNA Vaccines in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• ALK - Abello A/S (Denmark)
• Altimmune, Inc. (US)
• Bavarian Nordic A/S (Denmark)
• BiondVax Pharmaceuticals Ltd. (Israel)
• Bharat Biotech International Limited (India)
• GlaxoSmithKline Plc. (UK)
• Hualan Biological Engineering Inc. (China)
• Janssen Pharmaceuticals, Inc. (US)
• MedImmune (US)
• Merck & Co., Inc. (US)
• Pfizer Inc. (US)
• Sanofi Pasteur SA (France)
• Serum Institute of India Pvt. Ltd. (India)
• Shanghai BravoBio Co., Ltd. (China)
• Seqirus (UK)
• SK Chemicals Co., Ltd. (Korea)
• Takeda Pharmaceutical Company Limited (Japan)
• Zydus Cadila (India)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Recombinant DNA Vaccines in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Recombinant DNA Vaccines in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Recombinant DNA Vaccines Market Research Report 2016

1 RECOMBINANT DNA VACCINES MARKET OVERVIEW

1.1 Product Overview and Scope of Recombinant DNA Vaccines
1.2 Recombinant DNA Vaccines Segment by Type
  1.2.1 Global Production Market Share of Recombinant DNA Vaccines by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Recombinant DNA Vaccines Segment by Application
  1.3.1 Recombinant DNA Vaccines Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Recombinant DNA Vaccines Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Recombinant DNA Vaccines (2011-2021)

2 GLOBAL RECOMBINANT DNA VACCINES MARKET COMPETITION BY MANUFACTURERS

2.1 Global Recombinant DNA Vaccines Production and Share by Manufacturers (2015 and 2016)
2.2 Global Recombinant DNA Vaccines Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Recombinant DNA Vaccines Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Recombinant DNA Vaccines Manufacturing Base Distribution, Sales Area and Product Type
2.5 Recombinant DNA Vaccines Market Competitive Situation and Trends
  2.5.1 Recombinant DNA Vaccines Market Concentration Rate
  2.5.2 Recombinant DNA Vaccines Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL RECOMBINANT DNA VACCINES PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Recombinant DNA Vaccines Production and Market Share by Region (2011-2016)
3.2 Global Recombinant DNA Vaccines Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL RECOMBINANT DNA VACCINES SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Recombinant DNA Vaccines Consumption by Regions (2011-2016)
4.2 North America Recombinant DNA Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Recombinant DNA Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Recombinant DNA Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Recombinant DNA Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Recombinant DNA Vaccines Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Recombinant DNA Vaccines Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL RECOMBINANT DNA VACCINES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Recombinant DNA Vaccines Production and Market Share by Type (2011-2016)
5.2 Global Recombinant DNA Vaccines Revenue and Market Share by Type (2011-2016)
5.3 Global Recombinant DNA Vaccines Price by Type (2011-2016)
5.4 Global Recombinant DNA Vaccines Production Growth by Type (2011-2016)

6 GLOBAL RECOMBINANT DNA VACCINES MARKET ANALYSIS BY APPLICATION

6.1 Global Recombinant DNA Vaccines Consumption and Market Share by Application (2011-2016)
6.2 Global Recombinant DNA Vaccines Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL RECOMBINANT DNA VACCINES MANUFACTURERS PROFILES/ANALYSIS

7.1 ALK - Abello A/S (Denmark)
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Altimmune, Inc. (US)
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Altimmune, Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Bavarian Nordic A/S (Denmark)
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 BiondVax Pharmaceuticals Ltd. (Israel)
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Bharat Biotech International Limited (India)
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Bharat Biotech International Limited (India) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline Plc. (UK)
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Hualan Biological Engineering Inc. (China)
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Janssen Pharmaceuticals, Inc. (US)
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 MedImmune (US)
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 MedImmune (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Merck & Co., Inc. (US)
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Recombinant DNA Vaccines Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Merck & Co., Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Pfizer Inc. (US)
7.12 Sanofi Pasteur SA (France)
7.13 Serum Institute of India Pvt. Ltd. (India)
7.14 Shanghai BravoBio Co., Ltd. (China)
7.15 Seqirus (UK)
7.16 SK Chemicals Co., Ltd. (Korea)
7.17 Takeda Pharmaceutical Company Limited (Japan)
7.18 Zydus Cadila (India)

8 RECOMBINANT DNA VACCINES MANUFACTURING COST ANALYSIS

8.1 Recombinant DNA Vaccines Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Recombinant DNA Vaccines

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Recombinant DNA Vaccines Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Recombinant DNA Vaccines Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL RECOMBINANT DNA VACCINES MARKET FORECAST (2016-2021)

12.1 Global Recombinant DNA Vaccines Production, Revenue Forecast (2016-2021)
12.2 Global Recombinant DNA Vaccines Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Recombinant DNA Vaccines Production Forecast by Type (2016-2021)
12.4 Global Recombinant DNA Vaccines Consumption Forecast by Application (2016-2021)
12.5 Recombinant DNA Vaccines Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant DNA Vaccines
Figure Global Production Market Share of Recombinant DNA Vaccines by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Recombinant DNA Vaccines Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Recombinant DNA Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Recombinant DNA Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Recombinant DNA Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Recombinant DNA Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Recombinant DNA Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Recombinant DNA Vaccines Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Recombinant DNA Vaccines Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Recombinant DNA Vaccines Production of Key Manufacturers (2015 and 2016)
Table Global Recombinant DNA Vaccines Production Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant DNA Vaccines Production Share by Manufacturers
Figure 2016 Recombinant DNA Vaccines Production Share by Manufacturers
Table Global Recombinant DNA Vaccines Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Recombinant DNA Vaccines Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Recombinant DNA Vaccines Revenue Share by Manufacturers
Table 2016 Global Recombinant DNA Vaccines Revenue Share by Manufacturers
Table Global Market Recombinant DNA Vaccines Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Recombinant DNA Vaccines Average Price of Key Manufacturers in 2015
Table Manufacturers Recombinant DNA Vaccines Manufacturing Base Distribution and Sales Area
Table Manufacturers Recombinant DNA Vaccines Product Type
Figure Recombinant DNA Vaccines Market Share of Top 3 Manufacturers
Figure Recombinant DNA Vaccines Market Share of Top 5 Manufacturers
Table Global Recombinant DNA Vaccines Production by Regions (2011-2016)
Figure Global Recombinant DNA Vaccines Production and Market Share by Regions (2011-2016)
Figure Global Recombinant DNA Vaccines Production Market Share by Regions (2011-2016)
Figure 2015 Global Recombinant DNA Vaccines Production Market Share by Regions
Table Global Recombinant DNA Vaccines Revenue by Regions (2011-2016)
Table Global Recombinant DNA Vaccines Revenue Market Share by Regions (2011-2016)
Table 2015 Global Recombinant DNA Vaccines Revenue Market Share by Regions
Table Global Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table China Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table India Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Recombinant DNA Vaccines Consumption Market by Regions (2011-2016)
Table Global Recombinant DNA Vaccines Consumption Market Share by Regions (2011-2016)
Figure Global Recombinant DNA Vaccines Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Recombinant DNA Vaccines Consumption Market Share by Regions
Table North America Recombinant DNA Vaccines Production, Consumption, Import & Export (2011-2016)
Table Europe Recombinant DNA Vaccines Production, Consumption, Import & Export (2011-2016)
Table China Recombinant DNA Vaccines Production, Consumption, Import & Export (2011-2016)
Table Japan Recombinant DNA Vaccines Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Recombinant DNA Vaccines Production, Consumption, Import & Export (2011-2016)
Table India Recombinant DNA Vaccines Production, Consumption, Import & Export (2011-2016)
Table Global Recombinant DNA Vaccines Production by Type (2011-2016)
Table Global Recombinant DNA Vaccines Production Share by Type (2011-2016)
Figure Production Market Share of Recombinant DNA Vaccines by Type (2011-2016)
Figure 2015 Production Market Share of Recombinant DNA Vaccines by Type
Table Global Recombinant DNA Vaccines Revenue by Type (2011-2016)
Table Global Recombinant DNA Vaccines Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Recombinant DNA Vaccines by Type (2011-2016)
Figure 2015 Revenue Market Share of Recombinant DNA Vaccines by Type
Table Global Recombinant DNA Vaccines Price by Type (2011-2016)
Figure Global Recombinant DNA Vaccines Production Growth by Type (2011-2016)
Table Global Recombinant DNA Vaccines Consumption by Application (2011-2016)
Table Global Recombinant DNA Vaccines Consumption Market Share by Application (2011-2016)
Figure Global Recombinant DNA Vaccines Consumption Market Share by Application in 2015
Table Global Recombinant DNA Vaccines Consumption Growth Rate by Application (2011-2016)
Figure Global Recombinant DNA Vaccines Consumption Growth Rate by Application (2011-2016)
Table ALK - Abello A/S (Denmark) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure ALK - Abello A/S (Denmark) Recombinant DNA Vaccines Market Share (2011-2016)
Table Altimmune, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Altimmune, Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Altimmune, Inc. (US) Recombinant DNA Vaccines Market Share (2011-2016)
Table Bavarian Nordic A/S (Denmark) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bavarian Nordic A/S (Denmark) Recombinant DNA Vaccines Market Share (2011-2016)
Table BiondVax Pharmaceuticals Ltd. (Israel) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure BiondVax Pharmaceuticals Ltd. (Israel) Recombinant DNA Vaccines Market Share (2011-2016)
Table Bharat Biotech International Limited (India) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bharat Biotech International Limited (India) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bharat Biotech International Limited (India) Recombinant DNA Vaccines Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Plc. (UK) Recombinant DNA Vaccines Market Share (2011-2016)
Table Hualan Biological Engineering Inc. (China) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Hualan Biological Engineering Inc. (China) Recombinant DNA Vaccines Market Share (2011-2016)
Table Janssen Pharmaceuticals, Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Janssen Pharmaceuticals, Inc. (US) Recombinant DNA Vaccines Market Share (2011-2016)
Table MedImmune (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table MedImmune (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure MedImmune (US) Recombinant DNA Vaccines Market Share (2011-2016)
Table Merck & Co., Inc. (US) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck & Co., Inc. (US) Recombinant DNA Vaccines Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck & Co., Inc. (US) Recombinant DNA Vaccines Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant DNA Vaccines
Figure Manufacturing Process Analysis of Recombinant DNA Vaccines
Figure Recombinant DNA Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Recombinant DNA Vaccines Major Manufacturers in 2015
Table Major Buyers of Recombinant DNA Vaccines
Table Distributors/Traders List
Figure Global Recombinant DNA Vaccines Production and Growth Rate Forecast (2016-2021)
Figure Global Recombinant DNA Vaccines Revenue and Growth Rate Forecast (2016-2021)
Table Global Recombinant DNA Vaccines Production Forecast by Regions (2016-2021)
Table Global Recombinant DNA Vaccines Consumption Forecast by Regions (2016-2021)
Table Global Recombinant DNA Vaccines Production Forecast by Type (2016-2021)
Table Global Recombinant DNA Vaccines Consumption Forecast by Application (2016-2021)